Amandeep Mann
Family · Puyallup, WANPI 1669914354
Payments from drug & device makers
Across 36 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$387
- Boehringer Ingelheim$64
- Bayer$58
- Exact Sciences$53
- Echosens North America, Inc.$43
- Teva Pharmaceuticals USA, Inc.$37
- plus $134 from 7 others
What the payments were for
- Food & beverage$775100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $387 |
| Boehringer Ingelheim | 3 | $64 |
| Bayer | 2 | $58 |
| Exact Sciences | 2 | $53 |
| Echosens North America, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Novo Nordisk | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Edwards Lifesciences | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Abbott | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$775 in reported general payments places this provider in the 75th percentile of 1,706 family providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 12 | $28,935 |
| EliquisApixaban | 25 | $19,482 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,763 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,720 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $1,985 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,490 |
| Losartan Potassium | 177 | $1,454 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 46 | $1,332 |
| Atorvastatin Calcium | 190 | $1,314 |
| Levothyroxine Sodium | 142 | $1,251 |
| Amlodipine Besylate | 169 | $1,208 |
| Rosuvastatin Calcium | 83 | $1,180 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,139 |
| Diclofenac Sodium | 90 | $1,035 |
| Metoprolol Succinate | 74 | $989 |
Paid to pharmacies, not to this prescriber.
Other family in Puyallup
- Marina DolmatovaPuyallup$8K
- Mackenzie SchumannPuyallup$6K
- Patric SchineCentralia$842K
- Sharla PetersonKenmore$192K
- Zelda SwainSpokane$83K
- Savannah MorganRenton$76K
- Kevan PettersonSeattle$56K
- Kelly McFeeSunnyside$42K
- Cheryl SomersSpokane$31K
- Hye-Jin GehringBellevue$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.